emerg
respiratori
infecti
diseas
high
mortal
middl
east
respiratori
syndrom
mer
caus
novel
coronaviru
merscov
first
report
saudi
arabia
spread
eight
countri
develop
effect
therapeut
vaccin
crucial
save
live
halt
spread
merscov
show
recombin
protein
contain
acid
fragment
residu
truncat
receptorbind
domain
rbd
residu
merscov
spike
protein
fuse
human
igg
fc
fragment
highli
express
cultur
supernat
transfect
cell
purifi
protein
effici
bind
dipeptidyl
peptidas
receptor
merscov
potent
inhibit
merscov
infect
suggest
potenti
develop
therapeut
modal
treat
merscov
infect
save
patient
live
recombin
abl
induc
vaccin
mice
strong
merscov
sspecif
antibodi
block
bind
rbd
receptor
effect
neutral
merscov
infect
find
indic
truncat
rbd
protein
show
promis
develop
effect
safe
vaccin
prevent
merscov
infect
novel
human
coronaviru
middl
east
respiratori
syndrom
mer
coronaviru
merscov
identifi
pathogen
caus
sever
acut
respiratori
syndrom
sar
like
diseas
middl
east
europ
octob
world
health
organ
inform
confirm
case
merscov
infect
includ
death
case
fatal
rate
http
wwwwhointcsrdon
recent
report
famili
cluster
health
careassoci
transmiss
merscov
close
contact
proven
capac
humantohuman
transmiss
although
transmiss
significantli
lower
sar
coronaviru
sarscov
may
gain
increas
humantohuman
transmiss
evolut
potenti
caus
pandem
futur
accordingli
develop
effect
therapeut
vaccin
critic
earli
intervent
prevent
unlik
sarscov
use
human
angiotensinconvert
enzym
receptor
bind
cell
merscov
util
differ
receptor
dipeptidyl
peptidas
bind
cell
like
spike
protein
sarscov
protein
merscov
also
play
import
role
viru
entri
infect
merscov
protein
contain
subunit
mediat
viru
bind
cell
express
receptorbind
domain
rbd
region
subunit
mediat
viruscel
membran
fusion
base
sequenc
align
homolog
model
analysi
function
studi
mou
et
al
predict
rbd
locat
residu
merscov
subunit
fig
cocrystallograph
analys
complex
confirm
rbd
attribut
residu
merscov
fig
previou
studi
shown
rbd
sarscov
protein
significantli
inhibit
sarscov
infect
abl
induc
highli
potent
neutral
antibodi
protect
sarscov
infect
thu
expect
rbd
merscov
belong
betacoronaviru
genu
sarscov
may
also
effect
inhibit
merscov
infect
induc
neutral
antibodi
respons
infect
merscov
vaccin
anim
inde
identifi
rbd
acid
fragment
span
residu
could
bind
induc
neutral
antibodi
respons
immun
mice
rbd
report
mou
et
al
acid
fragment
span
residu
could
inhibit
merscov
infect
mgml
level
elicit
effect
neutral
antibodi
vaccin
rabbit
result
suggest
overlap
region
residu
must
contain
receptorbind
motif
rbm
major
neutral
epitop
rbd
crystallograph
analys
indic
rbm
locat
middl
residu
rbd
therefor
design
acid
truncat
rbd
sequenc
residu
fig
test
abil
inhibit
merscov
infect
induc
neutral
antibodi
respons
vaccin
mice
order
identifi
rel
optim
rbd
sequenc
develop
antimerscov
therapeut
vaccin
character
recombin
protein
contain
residu
merscov
protein
fuse
human
igg
fc
mou
et
al
shown
recombin
protein
contain
residu
merscov
human
igg
fc
fragment
induc
neutral
antibodi
respons
immun
mice
rabbit
thu
believ
truncat
rbd
sequenc
span
residu
includ
rbm
residu
may
contain
major
neutral
epitop
rbd
therefor
express
recombin
protein
contain
residu
fuse
human
iggfc
fig
found
protein
could
highli
express
cultur
supernat
transfect
cell
purifi
high
puriti
molecular
weight
nonboil
condit
almost
greater
boil
condit
sdspage
presenc
reduc
agent
fig
suggest
form
stabl
dimer
structur
reduc
condit
crosslink
analysi
appli
character
conform
structur
express
found
molecular
weight
crosslink
sampl
almost
higher
sampl
without
crosslink
fig
indic
merscov
fuse
fc
tag
abl
form
dimer
tetramer
conform
structur
band
fusion
protein
sdspage
confirm
western
blot
use
polyclon
antibodi
merscov
fig
detect
interact
protein
receptor
merscov
first
perform
coimmunoprecipit
analysi
mix
equal
concentr
purifi
solubl
presenc
protein
sepharos
bead
next
analyz
bound
protein
sdspage
western
blot
use
antibodi
specif
merscov
protein
respect
sdspage
fig
left
two
clear
band
respect
correspond
size
monom
shown
sampl
coimmunoprecipit
two
protein
one
band
correspond
size
indic
control
sampl
contain
respect
band
confirm
antibodi
merscov
shown
western
wb
right
analysi
use
polyclon
antibodi
c
analysi
protein
conform
crosslink
sampl
crosslink
glutaraldehyd
crosslink
final
concentr
mm
without
crosslink
wo
crosslink
follow
sdspage
left
wb
right
analysi
describ
protein
molecular
weight
marker
kda
invitrogen
indic
left
blot
fig
right
suggest
signific
bind
next
detect
interact
protein
cellular
receptor
cell
use
approach
similar
describ
replac
cell
lysat
previous
describ
expect
two
clear
band
correspond
size
respect
detect
protein
bead
preincub
mixtur
cell
lysat
react
strongli
polyclon
antibodi
merscov
monoclon
antibodi
mab
specif
fig
result
indic
merscov
abl
bind
effici
cellsurfac
receptor
subsequ
detect
bind
elisa
cellassoci
flow
cytometri
shown
figur
bound
coat
elisa
plate
dosedepend
manner
flow
cytometr
analysi
also
indic
dosedepend
bind
protein
cell
fig
howev
control
protein
higgfc
show
signific
bind
cellassoci
fig
result
confirm
bind
specif
evalu
potenti
inhibitori
activ
protein
merscov
infect
highli
permiss
human
bronchial
epitheli
cell
express
incub
multipl
infect
moi
presenc
serial
dilut
protein
viral
replic
indic
cytopath
effect
cpe
format
determin
h
postinfect
shown
figur
significantli
inhibit
merscov
infect
cell
dosedepend
manner
indic
diminish
reduc
cpe
format
specif
concentr
mgml
could
complet
nearli
complet
block
cpe
format
respect
protein
mgml
could
maintain
inhibit
cpe
format
howev
control
higgfc
protein
mgml
even
higher
data
shown
exhibit
inhibit
cpe
format
result
suggest
recombin
protein
potenti
develop
therapeut
merscov
infect
evalu
abil
protein
elicit
merscov
sspecif
antibodi
respons
immun
mice
subcutan
sc
use
purifi
protein
presenc
montanid
isa
adjuv
detect
igg
antibodi
respons
subtyp
neutral
antibodi
mous
sera
collect
differ
time
point
immun
result
demonstr
induc
increas
igg
antibodi
respons
boost
reach
highest
level
day
rd
vaccin
endpoint
titer
igg
approach
fig
antibodi
mous
sera
could
bind
effici
srbd
fusion
protein
fig
merscov
protein
without
fc
fig
suggest
antibodi
specif
rbd
subunit
merscov
protein
detect
igg
subtyp
antibodi
respons
reveal
abl
induc
antibodi
respons
vaccin
mice
fig
howev
pb
control
group
could
induc
signific
antibodi
respons
merscov
srbd
protein
fig
neutral
antibodi
sera
mice
day
postlast
vaccin
protein
evalu
live
merscovbas
neutral
assay
vero
cell
cultur
system
shown
figur
induc
high
neutral
antibodi
respons
neutral
antibodi
titer
mous
sera
pb
control
group
exhibit
signific
neutral
antibodi
merscov
result
suggest
protein
could
induc
potent
antimerscov
neutral
antibodi
respons
vaccin
anim
antibodi
antisera
mice
immun
protein
effect
block
bind
receptor
test
whether
mous
antibodi
could
block
rbd
bind
incub
cell
presenc
absenc
mous
antisera
describ
materi
method
follow
flow
cytometr
analysi
absenc
antisera
strong
signal
detect
cell
background
signal
observ
control
higgfcincub
cell
fig
confirm
truncat
rbd
could
specif
bind
cell
howev
presenc
antisera
bind
cell
effect
block
control
sera
pbsvaccin
mice
show
signific
inhibit
bind
cell
fig
high
mortal
sarslik
diseas
caus
merscov
humantohuman
transmiss
develop
effect
therapeut
vaccin
intervent
prevent
urgent
need
previou
studi
shown
rbd
sarscov
one
import
target
develop
sarscov
entri
inhibitor
sar
vaccin
therefor
use
similar
approach
identifi
optim
sequenc
rbd
merscov
protein
target
develop
antim
therapeut
vaccin
sever
group
independ
solv
crystal
structur
merscov
srbd
residu
contain
rbm
residu
fig
mou
et
al
group
shown
recombin
protein
contain
residu
respect
could
induc
merscov
neutral
antibodi
respons
immun
anim
suggest
overlap
region
span
residu
must
contain
major
neutral
epitop
base
find
design
truncat
rbd
fragment
contain
residu
contain
rbm
residu
merscov
protein
subunit
express
recombin
protein
cover
region
fuse
fc
human
igg
fusion
fc
tag
carri
order
facilit
affinitypurif
fccontain
fusion
protein
use
protein
bead
increas
immunogen
fccontain
protein
possibl
bind
fc
protein
fc
receptor
fcr
antigenpres
cell
apc
increas
vivo
halflif
stabil
fccontain
protein
format
stabl
dimer
tetramer
conform
structur
expect
purifi
fusion
protein
could
form
stabl
dimer
tetramer
structur
abl
bind
effici
well
cellsurfac
receptor
fig
result
potent
inhibit
merscov
infect
cell
fig
result
suggest
format
dimer
tetram
hinder
bind
receptor
thu
appear
much
potent
inhibit
merscov
infect
indic
remov
fragment
might
enhanc
effect
rbdmediat
antimerscov
activ
like
antibodi
recombin
protein
also
use
clinic
therapeut
treatment
cancer
data
present
mean
standard
deviat
sd
five
mice
per
group
abil
igg
bind
merscov
srbd
c
protein
detect
use
mous
sera
day
postlast
vaccin
abil
e
f
antibodi
bind
merscov
srbd
detect
use
sera
day
postlast
vaccin
data
present
mean
sd
five
mice
per
group
variou
dilut
point
peptidebas
hiv
entri
inhibitor
enfuvirtid
use
treat
hiv
infect
potent
inhibitori
activ
merscov
entri
recombin
protein
may
develop
merscov
entri
inhibitor
treatment
merscov
infect
acut
stage
major
concern
use
protein
drug
clinic
product
antibodi
may
suppress
drug
efficaci
howev
may
concern
merscov
srbd
proteinbas
therapeut
first
human
igg
fc
fusion
protein
expect
induc
antibodi
human
second
mainli
use
urgent
lifesav
treatment
earli
stage
merscov
infect
even
elicit
antirbd
antibodi
patient
sever
week
use
patient
may
pass
danger
acut
period
antibodi
induc
protein
drug
may
actual
help
patient
neutral
reenter
merscov
test
immunogen
truncat
rbd
merscov
protein
induc
antimerscov
immun
respons
neutral
antibodi
respons
vaccin
mice
notabl
elicit
elev
merscov
rbdspecif
igg
antibodi
respons
boost
reach
highest
level
rd
vaccin
fig
mous
antisera
exhibit
potent
neutral
antibodi
respons
neutral
antibodi
titer
much
higher
induc
data
suggest
truncat
rbd
fragment
contain
residu
immunogen
induc
rbdspecif
neutral
antibodi
respons
longer
rbd
fragment
contain
residu
possibl
ctermin
region
span
residu
contain
nonneutr
epitop
may
compet
neutral
epitop
residu
region
elicit
antibodi
respons
addit
residu
fragment
may
destabil
core
conform
rbd
analysi
crystal
structur
rbd
suggest
cystein
involv
stabil
tertiari
structur
rbd
form
disulfid
bond
respect
cystein
partner
extra
residu
eg
residu
nterminu
residu
cterminu
may
need
flank
cystein
proper
format
disulfid
bond
fig
howev
extend
region
cterminu
residu
may
advers
effect
tertiari
conform
core
structur
residu
therefor
truncat
rbd
fragment
residu
may
reach
optim
length
rbd
contain
intact
function
domain
rbm
residu
major
neutral
epitop
maintain
stabl
core
conform
previou
studi
shown
sarscov
srbdinduc
antibodi
effect
inhibit
sarscov
srbd
bind
receptor
sarscov
similarli
demonstr
antisera
mice
vaccin
truncat
srbd
merscov
could
also
effici
block
bind
merscov
srbd
receptor
indic
antibodi
mous
antisera
neutral
merscov
infect
possibl
inhibit
virusreceptor
bind
therefor
srbd
protein
antirbd
antibodi
develop
therapeut
treat
merscov
infect
necessari
test
therapeut
prevent
effect
truncat
srbd
anim
model
thu
far
howev
small
anim
model
establish
merscov
challeng
studi
lung
cell
syrian
hamster
express
receptor
merscov
report
anim
model
suscept
induct
merscov
infect
rhesu
macaqu
could
gener
pneumonialik
symptom
within
hour
merscov
infect
howev
macaqu
system
wide
applic
small
anim
model
therefor
await
establish
small
anim
model
order
carri
viral
challeng
studi
conclus
identifi
acid
truncat
rbd
subunit
merscov
protein
fuse
human
igg
fc
protein
denot
effect
bind
viral
receptor
potent
inhibit
merscov
infect
cell
also
induc
strong
rbdspecif
antibodi
respons
potent
neutral
activ
infect
merscov
therefor
truncat
srbd
link
fc
show
potenti
develop
therapeut
vaccin
treatment
prevent
merscov
infect
sixto
eightweekold
femal
balbc
mice
use
studi
anim
studi
carri
strict
accord
recommend
guid
care
use
laboratori
anim
nation
institut
health
protocol
approv
committe
ethic
anim
experi
new
york
blood
center
permit
number
construct
express
purif
recombin
merscov
protein
done
previous
describ
modif
briefli
gene
encod
residu
merscov
protein
amplifi
pcr
use
codonoptim
merscov
sequenc
genbank
templat
insert
express
vector
hereinaft
name
fc
invivogen
san
diego
ca
merscov
residu
plu
amplifi
insert
express
vector
jiangsu
taizhou
haiyuan
protein
biotech
co
ltd
china
sequenceconfirm
recombin
plasmid
transfect
cell
atcc
manassa
va
seed
h
transfect
follow
replac
cultur
medium
serumfre
dmem
invitrogen
carlsbad
ca
h
later
collect
supernat
contain
express
protein
h
posttransfect
recombin
protein
purifi
protein
affin
chromatographi
ge
healthcar
piscataway
nj
protein
fc
ninta
superflow
qiagen
valencia
ca
protein
tag
accord
manufactur
instruct
human
ectodomain
residu
express
purifi
previous
describ
human
ectodomain
briefli
human
ectodomain
contain
ntermin
honeybe
melittin
signal
peptid
ctermin
tag
express
insect
cell
use
bactobac
express
system
invitrogen
secret
cell
cultur
medium
subsequ
purifi
ninta
affin
column
gel
filtrat
column
ge
healthcar
purifi
protein
analyz
sdspage
western
blot
previous
describ
briefli
protein
either
boil
min
boil
separ
trisglycin
sdspage
gel
stain
coomassi
blue
transfer
nitrocellulos
membran
western
blot
analysi
block
nonfat
milk
pbst
overnight
blot
incub
h
room
temperatur
merscov
proteinspecif
polyclon
antibodi
develop
laboratori
three
wash
blot
incub
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
invitrogen
h
room
temperatur
signal
visual
ecl
western
blot
substrat
reagent
amersham
hyperfilm
ge
healthcar
protein
crosslink
done
previous
describ
briefli
mg
purifi
protein
mix
ml
glutaraldehyd
final
concentr
mm
left
room
temperatur
dark
h
sdspage
use
trisglycin
gel
western
blot
detect
describ
coimmunoprecipit
assay
bind
merscov
perform
coimmunoprecipit
assay
previous
describ
briefli
mg
cell
lysat
ml
respect
incub
merscov
protein
mg
plu
protein
sepharos
bead
h
wash
lysi
buffer
pb
bead
boil
min
subject
sdspage
western
blot
detect
use
mab
mgml
r
system
minneapoli
mn
merscov
protein
use
merscov
polyclon
antibodi
develop
laboratori
bind
merscov
cell
also
measur
flow
cytometri
briefli
cell
incub
variou
concentr
min
room
temperatur
follow
incub
goat
antihuman
igg
antibodi
min
analysi
flow
cytometri
human
igg
fc
concentr
use
control
inhibit
bind
cell
mous
antisera
perform
coincub
sera
merscov
mgml
cell
min
room
temperatur
stain
goat
antihuman
igg
mixtur
analyz
flow
cytometri
cell
highli
suscept
merscov
incub
serial
dilut
recombin
merscov
higgfc
control
protein
h
remov
media
contain
protein
cell
infect
merscoverasmu
medic
center
emc
multipl
infect
moi
h
thoroughli
wash
pb
remov
unbound
virus
infect
cultur
replenish
fc
medium
contain
aforement
protein
dilut
accordingli
follow
incub
addit
h
assess
format
cpe
done
previous
describ
immun
protocol
modif
briefli
mice
primevaccin
sc
mgmous
recombin
protein
formul
montanid
isa
adjuv
seppic
fairfield
nj
boost
twice
immunogen
adjuv
interv
sera
preimmun
day
posteach
vaccin
heatinactiv
minut
detect
sspecif
antibodi
respons
neutral
antibodi
blockag
receptor
bind
elisa
elisa
carri
detect
merscov
protein
bind
receptor
merscov
sspecif
antibodi
respons
collect
mous
sera
previous
describ
briefli
elisa
plate
respect
precoat
recombin
mgml
bind
merscov
protein
mgml
antibodi
respons
overnight
block
nonfat
milk
h
serial
dilut
merscov
protein
bind
mous
sera
antibodi
detect
ad
plate
incub
h
follow
four
wash
bound
antibodi
respect
incub
hrpconjug
antihuman
igg
bind
invitrogen
antimous
igg
antibodi
detect
invitrogen
h
reaction
visual
substrat
tmb
invitrogen
stop
h
absorb
nm
measur
elisa
plate
reader
tecan
san
jose
ca
standard
microneutr
assay
use
quantifi
neutral
potenti
specimen
previous
describ
briefli
serum
sampl
dilut
serial
tissu
cultur
plate
incub
room
temperatur
hour
infecti
merscov
well
transfer
result
mixtur
duplic
well
confluent
vero
cell
grown
tissu
cultur
plate
h
incub
viru
control
well
exhibit
advanc
virusinduc
cpe
neutral
capac
individu
serum
sampl
assess
determin
presenc
absenc
cpe
neutral
antibodi
titer
express
reciproc
highest
dilut
serum
complet
inhibit
virusinduc
cpe
least
well
